A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase
Clinical trial NCT02263079 · COMPLETED
Trial details
- NCT number
- NCT02263079
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-16
- Primary completion
- 2020-01-29
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.